tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Quince Therapeutics Updates on NALL Study Efficacy
PremiumCompany AnnouncementsQuince Therapeutics Updates on NALL Study Efficacy
2M ago
Quince Therapeutics presents data from patient-reported walking capacity at CNS
Premium
The Fly
Quince Therapeutics presents data from patient-reported walking capacity at CNS
2M ago
Quince Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial and Strong Financial Position
Premium
Ratings
Quince Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial and Strong Financial Position
2M ago
QNCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsQNCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Quince Therapeutics initiated with an Outperform at Citizens JMP
Premium
The Fly
Quince Therapeutics initiated with an Outperform at Citizens JMP
4M ago
Quince Therapeutics files to sell 6.67M shares of common stock for holders
Premium
The Fly
Quince Therapeutics files to sell 6.67M shares of common stock for holders
4M ago
Quince Therapeutics prices up to $22M placement of securities
PremiumThe FlyQuince Therapeutics prices up to $22M placement of securities
6M ago
Quince Therapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Quince Therapeutics Approves Key Proposals at Annual Meeting
6M ago
Quince Therapeutics tops 75% enrollment in pivotal Phase 3 NEAT clinical trial
Premium
The Fly
Quince Therapeutics tops 75% enrollment in pivotal Phase 3 NEAT clinical trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100